
Bronchiectasis
Bronchiectasis
The LITFL Critical Care Compendium is a comprehensive collection of pages concisely covering the core topics and controversies of critical care.

Bronchiectasis

Sildenafil: potent selective phosphodiesterase inhibitor; inhibition of cGMP-specific phosphodiesterase -> pulmonary vasodilator

Rifampicin: inhibits DNA-dependent RNA polymerase activity

Prothrombinex: human plasma derivative; The 3 factor prothrombin complex concentrate available in Australia

Propofol: IV hypnotic agent; potentiates the inhibitory transmitters glycine & GABA which enhance spinal inhibition.

Indications Contraindications: Choose the correct catheter Handy Hints: References and Links

Sotalol: anti-arrhythmic; low doses = non-selective beta receptor antagonist; high doses = prolongs action potential

Statins (HMG CoA reductase inhibitors) are the most widely used drugs for lowering serum cholesterol levels. Statins also have anti-inflammatory, anti-oxidant and immune-modulating effects (ie independent lipid-lowering effects) which may attenuate end-organ dysfunction in a number of syndromes

Sugammadex is used for reversal of the amino steroid neuromuscular blocking drugs rocuronium, vecuronium and pancuronium.

Tenecteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction, PE

Terlipressin: synthetic vasopressin analogue with relative specificity for the splanchnic circulation where it causes vasoconstriction in these vessels with a reduction in portal pressure.

Tirofiban: anti-platelet agent; glycoprotein IIb/IIIa antagonist -> stops platelet aggregation